Funder: National Institutes of Health
Due Dates: March 10, 2026 (Estimated)
Funding Amounts: Estimated total program funding: $3,000,000; 1 expected award; duration and annual amount not specified.
Summary: Supports the creation of a center to train and provide preclinical support for researchers developing new substance use disorder pharmacotherapies.
Key Information: This is a forecasted opportunity; applications are not being solicited yet.